REQUEST A DEMO
Total
USD $0.00
Search more companies

Lab Centro Illingworth S.A.S. (LCI) (Ecuador)

Main Activities: Medical and Diagnostic Laboratories
Full name: Lab Centro Illingworth S.A.S. (LCI) Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Lab Centro Illingworth S.A.S. (LCI) is a company in Ecuador, with a head office in Guayaquil. The enterprise currently operates in the Medical and Diagnostic Laboratories sector. It was incorporated on September 11, 2008. It currently has a total number of 22 (2023) employees. The latest financial highlights indicate a net sales revenue increase of 37.54% in 2023. Over the same period, its total assets grew by 75.93%. The enterprise’s net profit margin increased by 13.06% in 2023.

Headquarters
Av. del Ejercito 605
Guayaquil; Guayas;

Contact Details: Purchase the Lab Centro Illingworth S.A.S. (LCI) report to view the information.

Website: http://www.labcentro.com

Basic Information
Total Employees:
Purchase the Lab Centro Illingworth S.A.S. (LCI) report to view the information.
Outstanding Shares:
Purchase the Lab Centro Illingworth S.A.S. (LCI) report to view the information.
Registered Capital:
Purchase the Lab Centro Illingworth S.A.S. (LCI) report to view the information.
Incorporation Date:
September 11, 2008
Key Executives
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Lab Centro Illingworth S.A.S. (LCI) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
37.54%
Total operating revenue
36.35%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
264.03%
Total assets
75.93%
Total equity
124.49%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
13.06%
Return on Equity (ROE)
20.99%
Debt to Equity Ratio
-65.15%
Quick Ratio
-0.6%
Cash Ratio
-0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?